glp-1 and kidney function Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic disease through dampening the receptor for advanced glycation end products–induced inflammation Kidney effects of Glucagon-Like Peptide

Significant reduction in inflammation

10.1038/emboj.2012.149 95 ShangJ.CafaroJ.NehmerR.StoneJ

For a patient starting at 155/95 mmHg, that combined effect could bring readings into the 130 to 140 range, which aligns with 2017 ACC/AHA hypertension guideline targets [6]

chronic, maintenance of weight balance Synergy with leptin , amylin restores leptin sensitivity in obese models Synergy with CCK and GLP-1 , multi-pulse pathways of appetite suppression No tolerance , chronic administration of amylin preserves efficacy Why it matters: Lutzs review article established the scientific basis for amylin pharmacotherapy of obesity

Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion